Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02375009 · ClinicalTrials.gov registry record · NA
Glaucoma Management in the African-Derived Developing World Using Trabeculoplasty
A NA study, sponsored by West Virginia University.
- Completed
- Registry status
- NA
- Development phase
- 129
- Enrollment target
NCT02375009 is a NA study that has completed, run by West Virginia University. The registered enrollment target is 129 participants.
The verdict
NCT02375009, a NA study, has completed, sponsored by West Virginia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 129 participants
- Enrollment target
Study Summary
This proposal aims to evaluate selective laser trabeculoplasty (SLT) as a safe and effective therapy to control open-angle glaucoma and reduce the risk of progression to visual dysfunction or blindness in the African-derived developing world. If funded, this work will complete the characterization of SLT's safety and efficacy profile as a means of long-term disease control in this population. This work will support the translation of SLT into a structured public health initiative to reduce glaucoma-related vision loss throughout the African-derived developing world.
Interventions
- PROCEDURE Selective laser trabeculoplasty
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 129 participants |
| Start Date | 2015-03 |
| Est. Completion | 2018-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02375009
The ClinicalTrials.gov registry entry for NCT02375009 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 129 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is West Virginia University, which has 122 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Selective laser trabeculoplasty is the first listed.
NCT02375009 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02375009 about?
NCT02375009 is a clinical study titled "Glaucoma Management in the African-Derived Developing World Using Trabeculoplasty". This proposal aims to evaluate selective laser trabeculoplasty (SLT) as a safe and effective therapy to control open-angle glaucoma and reduce the risk of progression to visual dysfunction or blindness in the African-derived developing world. If funded, this work will complete the characterization o...
What is the current status of trial NCT02375009?
This trial is currently completed. It is a NA study. The enrollment target is 129 participants. The study started on 2015-03. Estimated completion is 2018-09.
What interventions are being tested in trial NCT02375009?
The interventions under investigation include: Selective laser trabeculoplasty (PROCEDURE).
Who is sponsoring clinical trial NCT02375009?
This trial is sponsored by West Virginia University, which has 122 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.